http://www.stemcellindex.com Stem Cell Index of companies and stell cell stocks. The stem cell index is the newest and hottest stocks listed on the major exchanges. profit today from these companies. en-us Sat, 04 Sep 2010 12:59:54 CDT Sat, 04 Sep 2010 12:59:54 CDT http://www.stemcellindex.com/ Stem Cell Index of companies and stell cell stocks. The stem cell index is the newest and hottest stocks listed on the major exchanges. profit today from these companies. Sat, 04 Sep 2010 12:59:54 CDT http://www.stemcellindex.com/articles/112055/Nutra-Pharma-(OTCBB:NPHC)... ... 2010-08-19 http://www.stemcellindex.com/articles/112059/Human-Embryonic-Stem-Cell-Market-... ... 2010-08-19 http://www.stemcellindex.com/articles/38193/Pluristem-Therapeutics-PTSI... Pluristem Therapeutics (NASDAQ: PSTI Pluristem Therapeutics Inc., a development stage bio-therapeutics company, engages in the research, development, and production of placental-derived adherent stromal cells (ASCs). The company also involves in the commercialization of non-personalized (allogeneic) cell therapy products for the treatment ... 2009-10-17 http://www.stemcellindex.com/articles/38194/Osiris-Therapeutics-OSIR... Osiris Therapeutics NASDAQ: OSIR Osiris Therapeutics, Inc., a stem cell therapeutic company, develops products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas in the United States. The company’s principal product includes Prochymal, which is in phase III clinical trials for the treatment of steroid refractory... 2009-10-17 http://www.stemcellindex.com/articles/34916/ThermoGenesis-(KOOL)... ThermoGenesis (KOOL)Thermogenesis Corp.2711 Citrus RoadRancho Cordova, CA 95742United States - MapPhone: 916-858-5100Fax: 916-858-5199Web Site: http://www.thermogenesis.com Sector: Healthcare Industry: Medical Appliances & Equipment ThermoGenesis Corp. designs, manufactures, and markets automated and semi-automated devices, and single-use pro... 2009-09-23 http://www.stemcellindex.com/articles/26217/Aastrom-Biosciences--ASTM... Aastrom Biosciences, Inc. (Nasdaq:ASTM - News), a leading developer of autologous adult stem cell treatments for severe chronic cardiovascular diseases, today announced that George Dunbar, President and Chief Executive Officer, will present at the Maxim Group Growth Conference. The conference will be held on Tuesday, September 29th at the Grand Hya... 2009-08-24 http://www.stemcellindex.com/articles/24092/Cell-Therapeutics,-Inc... Cell Therapeutics, Inc. (CTIC)Cell Therapeutics, Inc., a biopharmaceutical company, develops, acquires, and commercializes oncology products for cancer treatment. Its development portfolio includes Pixantrone, a phase III trial product, for non-Hodgkin’s lymphoma; Brostallicin, which is in first-line Phase II study for the treatment of sarcoma;... 2009-08-16 http://www.stemcellindex.com/articles/16368/RTI-Biologics-(RTIX)... RTI Biologics (RTIX) RTI Biologics, Inc.11621 Research CircleAlachua, FL32615United States-MapPhone: 386-418-8888Fax: 386-418-0342Web Site: http://www.rtix.comRTI Biologics, Inc., together with its subsidiaries, produces orthopedic and other surgical implants that repair and promote the natural healing of human bone and other hum... 2009-06-15 http://www.stemcellindex.com/articles/15179/Cytori-Therapeutics,-Inc.... Cytori Therapeutics, Inc.3020 Callan RoadSan Diego, CA92121United States-MapPhone: 858-458-0900Fax: 858-458-0994Web Site: http://www.cytoritx.comCytori Therapeutics, Inc. engages in the development, manufacture, and sale of medical technologies to enable the practice of regenerative medicine. The company develops its product pipel... 2009-06-08 http://www.stemcellindex.com/articles/14887/Stem-Cell-Companies... BioMimetic Therapeutics (BMTI)Cytori Therapeutics (CYTX) RTI Biologics (RTIX) Aastrom Biosciences (ASTM)Mesoblast (MBLTY) Neuralstem (CUR)Osteotech (OSTE) ThermoGenesis (KOOL) RegeneRx Biopharma (RGN) Advanced Cell Tecchology (ACTC) Pluristem Therapeutics (PSTI) Athersys (ATHX) International Stem Cell Corp (ISCO) Stem Cell Innovations (SCLL)Biohear... 2009-06-07 http://www.stemcellindex.com/articles/14895/Stem-Cell-Stocks... ASTM $0.36 -0.01 -2.14% 609,769 43% $57.2M 140% -54% 1 Alert (0 News) - View CUR $1.19 -0.01 -0.83% 117,385 217% $40.1M 59% -47% 1 Alert (0 News) - View CYTX $4.37 -0.17 -3.74% 634,194 102% $128.0M 208% -49% No Alerts/News GERN $6.83 -0.15 -2.... 2009-06-07 http://www.stemcellindex.com/articles/14896/BioMimetic-Therapeutics-(BMTI)... BioMimetic Therapeutics (BMTI)BioMimetic Therapeutics Inc.389-A Nichol Mill LaneFranklin, TN37067United States-MapPhone: 615-844-1280Fax: 615-844-1281Web Site: http://www.biomimetics.comBioMimetic Therapeutics, Inc. develops and commercializes regenerative protein therapeutic-device combination products. Its products are primarily... 2009-06-07 http://www.stemcellindex.com/headlines/news/xoma xoma News Headline :Stem Cell Index of companies and stell cell stocks. The stem cell index is the newest and hottest stocks listed on the major exchanges. profit today from these companies. Sat, 04 Sep 2010 12:59:54 CDT http://www.stemcellindex.com/resources/partners Other Resources :Stem Cell Index of companies and stell cell stocks. The stem cell index is the newest and hottest stocks listed on the major exchanges. profit today from these companies. Sat, 04 Sep 2010 12:59:54 CDT http://www.stemcellindex.com/watch/videos Videos :Stem Cell Index of companies and stell cell stocks. The stem cell index is the newest and hottest stocks listed on the major exchanges. profit today from these companies. Sat, 04 Sep 2010 12:59:54 CDT http://www.stemcellindex.com/information/contact Contact us :Stem Cell Index of companies and stell cell stocks. The stem cell index is the newest and hottest stocks listed on the major exchanges. profit today from these companies. Sat, 04 Sep 2010 12:59:54 CDT http://www.stemcellindex.com/exm/Hot_Stem_Cell_Stocks/ Stem Cell Stocks (*RXSTM) 2009-06-16 http://www.stemcellindex.com/exm/Stem_Cell_Guidelines/ Embryonic Stem Cell Research Expands With U.S. Funds (Update1)  Stem cell research in the U.S. will expand under rules that allow federal government funding for scientists working with unused embryos created at fertility clinics, freeing hundreds of cell lines for st... 2009-07-06 http://www.stemcellindex.com/exm/Stem_Cell_Stock_News/ Neuralstem gets FDA OK http://www.google.com/finance?chdnp=1&chdd=1&chds=1&chdv=1&chvs=maximized&... 2009-08-07 http://www.stemcellindex.com/exm/Market_Data/ ... 2009-08-25 http://www.stemcellindex.com/exm/CYTX/ Cytori Therapeutics Inc. (CYTX) said it has gotten approval from the Food and Drug Administration to sell what it calls the first device in the U.S. cleared for using a patient's own fat for cosmetic purposes. Shares rose 15.7% premarket to $7.50. Cytori's PureGraft system allows a patient'... 2010-01-08 http://www.stemcellindex.com/news/970086/-Xoma-Rockets-On-FDA-Drug-Designation... Xoma Rockets On FDA Drug Designation... Wed, 04 Aug 2010 10:18:34 -0700 http://www.stemcellindex.com/news/970087/-XOMA-052-Designated-Orphan-Drug-by-FDA-for-Treatment-of-Behcets-Disease... BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Food and Drug Administration has designated XOMA 052, an antibody to interleukin-1 beta, an orphan drug for the treatment of Behcets disease.... Wed, 04 Aug 2010 05:00:00 -0700 http://www.stemcellindex.com/news/970088/-XOMA-to-Announce-2010-Second-Quarter-Financial-Results-and-Host-Webcast-Conference-Call-on-August-9,-2010... BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of antibody therapeutics, announced that the company will host a webcast conference call on Monday, August 9, 2010 at 4:30 pm Eastern time to discuss its 2010 second quarter financial results and provide a general business update.... Mon, 02 Aug 2010 05:00:00 -0700 http://www.stemcellindex.com/news/970089/-XOMA-052-Orphan-Drug-Designation-for-Behcets-Disease-Recommended-by-European-Medicines-Agency... BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, announced that the Committee for Orphan Medical Products of the European Medicines Agency has adopted a positive opinion and recommends the granting of orphan medicinal product designation for XOMA 052, an antibody to interleukin-1 beta, for the tr... Thu, 29 Jul 2010 05:00:00 -0700 http://www.stemcellindex.com/news/970090/-Biotech-Stocks:-Depomed,-Dendreon-lead-drug-stocks-higher... Depomed lead gains among drug stocks a day after it said Pfizer will not file a patent infringement lawsuit to prevent the launch of a painkiller.... Wed, 04 Aug 2010 07:55:59 -0700 http://www.stemcellindex.com/news/970091/-Trader-Favorite-Dendreon-Spikes-On-Provenge-Sales... After soaring higher on the FDA approval of its Provenge prostate cancer vaccine in April, volatile Dendreon quickly retreated to well below its pre-approval pricing, but sales figures perked up the bulls on Wednesday.... Wed, 04 Aug 2010 08:00:00 -0700 http://www.stemcellindex.com/news/970092/-Most-active-Nasdaq-traded-stocks... A look at Nasdaq 10 most-active stocks at 1 p.m.: Cisco Systems Inc. rose 1.3 percent to $24.14 with 27,982,500 shares traded.... Wed, 04 Aug 2010 10:19:20 -0700 http://www.stemcellindex.com/news/970093/-XOMA-Receives-$750,000-Milestone-Payment-From-AVEO-Pharmaceuticals... XOMA Ltd. /quotes/comstock/15*!xoma/quotes/nls/xoma (XOMA 0.34, +0.01, +1.99%) , a leader in the discovery and development of therapeutic antibodies, announced receipt of a $750,000 milestone payment under its collaboration with AVEO Pharmaceuticals, Inc.... Mon, 26 Jul 2010 07:57:24 -0700 http://www.stemcellindex.com/news/970094/-EMA-recommends-orphan-medicinal-product-designation-for-XOMA-052-in-treatment-of-Behcets-disease... XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that the Committee for Orphan Medical Products of the European Medicines Agency (EMA) has adopted a positive opinion and recommends the granting of orphan medicinal product designation for XOMA 052, an antibody to interleukin-1 beta, for the treatment of Behc... Thu, 29 Jul 2010 05:36:55 -0700 http://www.stemcellindex.com/news/970095/-Insulin-resistance-from-obesity-is-lowering-childrens-cognitive-performance:-Research... A study by researchers at NYU Langone Medical Center have found that obese adolescents with type 2 diabetes have diminished cognitive performance and subtle abnormalities in the brain as detected by Magnetic Resonance Imaging (MRI). Identification of cognitive impairments as a complication of type 2 diabetes emphasizes the importance of addressing... Tue, 03 Aug 2010 01:21:35 -0700